Please login to the form below
Sunshine Act
This page shows the latest Sunshine Act news and features for those working in and with pharma, biotech and healthcare.
The changing face of medical communications over the past 15 years
The introduction of the Physician Payments Sunshine Act in 2010 has increased the transparency of financial relationships between healthcare professionals and pharma in the USA.
Latest news
-
UK HCPs back transparency over their pharma payments
The initiative in Europe is led by the industry, unlike the US where the Physician Payment Sunshine Act implemented a federally-mandated disclosure requirement, with the first figures published earlier this
-
Government crackdown on doctor-pharma payments
The ABPI said it welcomes Hunt's announcement of a new 'Sunshine Rule'. ... Sunshine Rule' develop, to ensure that we maximise our combined efforts on disclosure for the benefit of patients and the public.
-
Payment to docs rules ‘an opportunity for pharma’
We must keep going, however, and communicate the need for a symbiotic relationship with HCPs to counter-act the suspicions of the public and the media that are so evident from ... This also comes as the so-called Sunshine Act in the US came into force
-
Daiichi Sankyo pays $39m in whistleblower case
Under the whistleblower provisions of the False Claims Act, Fragoules will take a $6.1m share of the settlement. ... The Physician Payment Sunshine Act - which came into effect in August 2013 - is expected to make the practices alluded to in this civil
-
The impact of the US Sunshine Act
The financial relationship between pharma and doctors in the US reached a watershed moment this year as the so-called 'Sunshine Act' showed for the first time just how much the ... The Physician Payment Sunshine Act, to give the law its full name, was
More from news
Approximately 8 fully matching, plus 12 partially matching documents found.
Latest Intelligence
-
US health reforms
Is the stage set for price controls in the US? Most stakeholders in the US healthcare marketplace would prefer to see the Affordable Care Act survive ongoing efforts at repeal and ... Also, in the US, national law often begins life as state law, for
-
Searching for health
All this is done against a backdrop of the French State raising the compliance stakes and introducing its own 'Sunshine Act' to improve accountability.
-
Counting down to the EFPIA Disclosure Code
The concern is that these benefits to the patient and healthcare could get submerged in a similar deluge of headlines that greeted the arrival of the Physician Payment Sunshine Act, as ... part of the 2010 Affordable Care Act, which laid bare payments in
-
Could EFPIA's new code boost pharma's reputation?
headlines.”. This also comes as the so-called Sunshine Act in the US came into force last year revealing around $3.5bn worth of money was paid by the industry to
More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.
Latest from PMHub
-
The changing face of medical communications over the past 15 years
The introduction of the Physician Payments Sunshine Act in 2010 has increased the transparency of financial relationships between healthcare professionals and pharma in the USA.
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- BioNTech bolsters COVID-19 vaccine capacity with Novartis deal
- New study identifies drugs that are safe to use in COVID-19 treatment
- Pfizer’s ALK inhibitor Lorbrena hits the mark in head-to-head lung cancer trial
- BMS eyes approval for second Opdivo combo in kidney cancer
- New medical communications agency BOLDSCIENCE launches
- Moderna inks R&D agreements with Vertex and Chiesi
- FDA hands BMS and bluebird bio a priority review for ide-cel
- Janssen’s EGFR-targeting treatment regimen shows early benefit in lung cancer
- Relief Therapeutics seeks US emergency approval for COVID-19 drug
- Could formulary intelligence be your brand differentiator?
- How COVID-19 is accelerating the threat of antimicrobial resistance
- Porterhouse Medical strengthens its senior management team
PMHub
Valid Insight
Valid Insight is an award-winning pharmaceutical global market access consultancy....
Latest intelligence
- Could formulary intelligence be your brand differentiator?
- Proprietary research, and the COVID-19 experience, shows how formulary intelligence can drive competitive advantage at launch...
- How COVID-19 is accelerating the threat of antimicrobial resistance
- Why antimicrobial resistance needs to be addressed with the same urgency as COVID-19...
- Improve clinical trials through patient journey mapping
- Could patient journey mapping be your solution to improving clinical study recruitment and retention? While awareness of clinical studies is low across the population, it’s not the only issue. It’s...
Quick links
Infographics
